Clinical Trial Update: Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing celecoxib to diclofenac in ankylosing spondylitis has completed, evaluating comparative safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Celecoxib (Celecoxib)
• Diclofenac (diclofenac)

Snippet

Sponsor: Pfizer | Conditions: Spondylitis, Ankylosing | Phase 3 | Status: COMPLETED